Velopharyngeal Insufficiency Following Furlow Versus Straight Line Repair With Intravelar Veloplasty: A Single-institution Experience

被引:1
|
作者
Davis, Matthew J. [1 ,2 ]
Roy, Michelle G. [1 ,2 ]
Burns, Heather R. [1 ,2 ]
Yim, Nicholas [1 ]
Wilson, Kristina D. [3 ]
Moore, Ellen E. [3 ]
Buchanan, Edward P. [1 ,2 ]
Monson, Laura A. [1 ,2 ,4 ]
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Plast Surg, Houston, TX USA
[2] Texas Childrens Hosp, Dept Surg, Div Plast Surg, Houston, TX USA
[3] Texas Childrens Hosp, Speech Language & Learning, Language, Houston, TX USA
[4] Mark A Wallace Tower,Suite 610,6701 Fannin St, Houston, TX 77030 USA
关键词
Cleft palate; Furlow; hypernasality; intravelar veloplasty; velopharyngeal function; CLEFT-PALATE REPAIR; OPPOSING Z-PLASTY; REVERSING Z-PLASTY; 2-FLAP PALATOPLASTY; NASOMETRIC VALUES; SPEECH; SURGERY; MANAGEMENT; OUTCOMES; FISTULA;
D O I
10.1097/SCS.0000000000009874
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background:Measurements of postoperative velopharyngeal dysfunction (VPD) can be used to determine the efficacy of a palatoplasty operation. Hypernasality and audible nasal air emission are typical manifestations of VPD during speech. We aimed to longitudinally compare VPD outcomes in postpalatoplasty patients who underwent Furlow repair versus straight line repair with intravelar veloplasty (IVVP). Additionally, we examined the relationship between VPD outcomes and select pre-existing patient characteristics.Methods:Retrospective chart review was performed to identify primary palatoplasty patients treated from April 2012 to March 2021. Variables collected included gender, syndromic status, primary language, Veau cleft type, type of speech assessment, age at time of surgery, degree of hypernasality, presence of audible nasal air emission, and overall adequacy of velopharyngeal function. Pearson chi 2 test and multivariable t tests were used to analyze variables. Logistic regression was used to control for statistically significant variables.Results:Of the 118 patients included, 38 received a Furlow procedure and 80 received a straight line with IVVP procedure. Audible nasal air emission was present in 57.3% of straight line with IVVP patients and 42.9% of Furlow patients, with no statistically significant difference between groups. Clinically significant hypernasality was present in 42.1% of straight line with IVVP patients and 22.9% of Furlow patients (P=0.05). Velopharyngeal function was classified as adequate in 63.5% of straight line with IVVP patients and 83.3% of Furlow patients (P=0.03). However, after stratifying by syndromic versus nonsyndromic status, there was no statistically significant difference between straight line with IVVP and Furlow patients for postoperative hypernasality and velopharyngeal function.Conclusions:This study suggests that there are no statistically significant differences between straight line with IVVP and Furlow palatoplasty techniques regarding speech outcomes including hypernasality, audible nasal air emission, and overall VP function. Furthermore, select patient characteristics such as gender, primary language, syndromic status, age at repair, and Veau cleft type do not significantly impact postoperative speech outcomes.
引用
收藏
页码:547 / 552
页数:6
相关论文
共 39 条
  • [31] In Reply: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience
    Chicoine, Michael R.
    Kim, Albert H.
    NEUROSURGERY, 2021, 89 (03) : E176 - E177
  • [32] Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience
    Ong, Wee Loon
    Nazareth, Lester
    Hindson, Benjamin
    Matheson, Bronwyn
    Millar, Jeremy L.
    JOURNAL OF MEDICAL RADIATION SCIENCES, 2016, 63 (03): : 161 - 169
  • [33] Short-Term Outcome of Clipping Versus Coiling of Ruptured Intracranial Aneurysms Treated by Dual-Trained Cerebrovascular Surgeon: Single-Institution Experience
    Zanaty, Mario
    Chalouhi, Nohra
    Starke, Robert M.
    Daou, Badih
    Todd, Michael
    Bayman, Emine
    Torner, James
    Hasan, David
    WORLD NEUROSURGERY, 2016, 95 : 262 - 269
  • [34] Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience
    Allen, Casey J.
    Blumenthaler, Alisa N.
    Smith, Grace L.
    Das, Prajnan
    Minsky, Bruce D.
    Blum, Mariela
    Ajani, Jaffer
    Mansfield, Paul F.
    Ikoma, Naruhiko
    Badgwell, Brian D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) : 758 - 765
  • [35] Outcomes of open versus single-incision laparoscopic totally extraperitoneal inguinal hernia repair using propensity score matching: A single institution experience
    Lee, Kanghee
    Lee, Jin Ho
    Nam, Soomin
    Chong, Jae Uk
    Lee, Hyung Soon
    PLOS ONE, 2021, 16 (01):
  • [36] Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience
    Lei, Kunyang
    Wang, Xu
    Yang, Zhongsheng
    Zhong, Yuming
    Liu, Yifu
    Sun, Ting
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [37] A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer
    Cecchini, Michael
    Miccio, Joseph A.
    Pahade, Jay
    Lacy, Jill
    Salem, Ronald R.
    Johnson, Skyler B.
    Blakaj, Adriana
    Stein, Stacey
    Kortmansky, Jeremy S.
    Johung, Kimberly L.
    PANCREAS, 2020, 49 (07) : 904 - 911
  • [38] Long-term outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for gastric cancer: a 10-year single-institution experience
    Wang, Hao
    Mou, Tingyu
    Chen, Hao
    Hu, Yanfeng
    Lin, Tian
    Li, Tuanjie
    Yu, Jiang
    Liu, Hao
    Li, Guoxin
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2019, 33 (01): : 135 - 144
  • [39] The Efficacy and Safety of Inetetamab and Pyrotinib in Combination with Vinorelbine for Second-line Therapy and Beyond in HER2-positive Metastatic Breast Cancer: A Single-institution Clinical Experience
    Wu, Fan
    Chen, Mulan
    Wang, Lili
    Li, Nani
    Wu, Xiufeng
    Chen, Xinhua
    Hong, Yi
    Li, Chongyin
    Lin, Lin
    Chen, Kan
    Huang, Weiwei
    Liu, Jian
    CURRENT CANCER DRUG TARGETS, 2024, 24 (05) : 490 - 500